Appointment booking for Dr. Venkat Kalapatapu, MD is currently not available.Dr. Venkat Kalapatapu, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Venkat Kalapatapu, MD (he/him) is a Surgeon, Vascular Surgeon in Philadelphia, PA with over 18 years of experience. What is your opinion of Dr. Venkat Kalapatapu, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Venkat Kalapatapu, MD has received over $17,075 which includes payments from the following companies:
$12,445.58 from Endologix, Inc.
$1,548.71 from Bolton Medical Inc
$868.17 from Silk Road Medical, Inc.
$474.45 from Cook Medical LLC
$446.56 from Maquet Cardiovascular U.S. Sales, L.L.C.
$246.94 from Cook Incorporated
$232.70 from Medtronic Vascular, Inc.
$181.70 from W. L. Gore & Associates, Inc.
$146.11 from Maquet Cardiovascular L.L.C.
$107.60 from Boston Scientific Corporation
$93.42 from Terumo Medical Corporation
$93.26 from Abbott Laboratories
$85.72 from Cardinal Health 200, LLC
$25.46 from CryoLife, Inc.
$24.90 from Bard Peripheral Vascular, Inc.
$22.24 from Smith & Nephew, Inc.
$21.00 from KCI USA, Inc
$10.98 from TriVascular, Inc.
Payments received by Dr. Venkat Kalapatapu, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!